Press
Release

Altimmune to Present at Upcoming Investor Conferences

November 10, 2021 at 4:01 PM EST

GAITHERSBURG, Md., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following investor conferences in November 2021:

  • Stifel’s 2021 Virtual Healthcare Conference
    Monday, November 15, 2021
    10:40 am Eastern Time
  • Jefferies London Healthcare Conference
    Thursday, November 18, 2021
    8:00 am GMT

The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™).   For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Altimmune Investor & Media Contact:

Will Brown
Chief Financial Officer
Phone:   240-654-1450
wbrown@altimmune.com


Primary Logo

Source: Altimmune, Inc

 

Investor Contact

Will Brown
Chief Financial Officer

Email: wbrown@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe